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Abstract 
Azoospermia, the absence of spermatozoa in ejaculate due to testicular failure or reproductive 
tract obstruction, is the most unfavorable form of male infertility and is found in approximately 15% 
of infertile men. We report a 34 years old man with primary infertility for 4 years due to azoospermia. 
There were bilateral varicoceles grade 2, low level of serum testosterone and luteinizing hormone and 
normal level of serum folicle stimulating hormone (FSH) on the low margin. The patient underwent 
sperm extraction (PESA and TESE method) with result there were no motile spermatozoa. On the 
spermatogenesis examination, it was revealed that the spermatogenesis process stopped on the 
spermatid phase. We decided to perform bilateral spermatic vein microligation followed by hormonal 
injection (HCG and FSH recombinant) for 4 months. On the evaluation, there was motile spematozoa 
on the left PESA. This finding suggested the effectiveness of the therapy, there was a spermatogenesis 
on this patient after bilateral spermatic vein microligation and combination hormonal therapy of HCG 
and FSH recombinant for 4 months.
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Mikroligasi Vena Spermatika Bilateral, dan Terapi Kombinasi
Human Chorionic Gonadotropin serta Folicle Stimulating
Hormone Rekombinan pada Pasien dengan Azoospermia
Abstrak
Azoospermia, tidak adanya spermatozoa dalam ejakulat akibat kegagalan testis atau 
obstruksi saluran reproduksi, adalah bentuk paling menguntungkan pada infertilitas pria dan 
ditemukan sekitar 15% pada pria tidak subur. Kami melaporkan seorang pria berusia 34 tahun 
dengan infertilitas primer selama 4 tahun karena azoospermia. Terdapat varicocele bilateral tingkat 
2, kadar testosteron serum dan luteinizing hormone rendah sedangkan kadar folicle stimulating 
hormone (FSH) normal pada nilai rendah rendah. Pasien menjalani ekstraksi sperma (metode 
PESA dan TESE) dengan hasil tidak ada spermatozoa motil. Pada pemeriksaan spermatogenesis, 
ditemukan bahwa proses spermatogenesis berhenti pada fase spermatid. Kami memutuskan 
untuk melakukan mikroligasi vena spermatika bilateral diikuti dengan injeksi hormon (HCG, dan 
FSH rekombinan) selama 4 bulan. Pada evaluasi, ada  spematozoa motil pada PESA kiri. Temuan 
ini menunjukkan efektivitas terapi, yaitu terjadi spermatogenesis pada pasien mikroligasi vena 
spermatika bilateral dan terapi hormonal kombinasi HCG dan FSH rekombinan selama 4 bulan.
Keywords: infertilitas primer, azoospermia, HCG, FSH rekombinan, mikroligasi vena 
spermatika 
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Introduction 
Azoospermia is defined as the absence 
of spermatozoa in microscopic examination 
of centrifuged semen in two examinations.1 
Azoospermia was found in approximately 1% of 
men and 15% of infertile men.2,3 This condition must 
be evaluated for its etiology in order to determine 
the existing risk factors, the prognosis and the 
appropriate management of the patient.
Generally azoospermia can be divided into 
3 categories: pre-testicular, testicular and post-
testicular. Pre-testicular abnormalities are hormonal 
disorders that affect the spermatogenetic process 
and are quite rare. The frequency of azoospermia 
caused by low gonadotropins was found to be less 
than 0.5% of cases. Testicular abnormalities are 
caused by failure of spermatogenetic process due 
to intrinsic abnormalities in the testis either primary, 
or due to some other process in the testis. Post-
testicular abnormalities are caused by obstruction 
along the ejaculatory ducts or due to failure of the 
ejaculation process itself.1,4
The most common etiology found in 
azoospermia is varicocele, which is found in 
approximately 12%-20% of men. Varicocele is an 
abnormal dilatation of the pampiniform plexus that 
can cause failure of growth and development of the 
testes as well as the spermatogenesis process. 
There is still a debate about the direct relationship of 
varicocele with infertility, but some studies suggest 
that varicocele surgery or varicocelectomy were 
found to have therapeutic effects for both fertility 
and testicular development. 5-8
In this paper, we will discuss one case of primary 
infertility in a male patient with bilateral varicocele 
and hypogonadism who showed a positive response 
to bilateral varicocelectomy and hormonal injection.
Case report
A man aged 34 years old came to the 
outpatient unit in March 2012 with a chief complaint 
of not having children at four years of marriage. 
There were no erection, penetration or ejaculation 
dysfunctions. The patient had sexual intercourse 
with his wife on a regular basis with a frequency of 
once per week. There was no history of diabetes 
mellitus, mumps, sexually transmitted diseases, 
reproductive tract infection, urinary tract infection, 
radiation and trauma. The patient did not smoke. 
There were no routine exposures to extreme 
temperatures. The development of secondary sex 
characteristics appeared to be fine. No identical 
abnormalities from the same side of the family and 
no abnormalities in the patient’s wife were found.
Of the physical examination, the patient was 
in good condition. No ginecomastia and abnormal 
urethral orifice location were observed. Both 
testes were normal on palpation. Initial laboratory 
examination showed normal follicle stimulating 
hormone (FSH) level (low margin) and low luteinizing 
hormone (LH) and serum testosterone levels 
(Table 1). Sperm analysis showed azoospermia. 
Ultrasound performed on the patient demonstrated 
homogeneous structure for both testis, left testis 
size of 16.6 cm3 and right testis size of 12.4 cm3, 
a 0.65 cm cyst on the left epididymal head, left 
epididymal head enlargement, and widened 
bilateral pampiniform plexus.
The patient did not smoke. There were no routine exposures to extreme temperatures. The 
development of secondary sex characteristics appeared to be fine. No identical abnormalities 
from the same side of the family and no abnormalities in the patient's wife were found. 
 Of the physical examination, the patient was in good condition. No ginecomastia and 
abnormal urethral orifice location were observed. Both testes were normal on palpation. Initial 
laboratory examination showed normal follicle stimulating hormone (FSH) level (low margin) 
and low luteinizing hormone (LH) and serum testosterone levels (Table 1). Sperm analysis 
showed azoospermia. Ultrasound performed on the patient demonstrated homogeneous 
structure for both testis, left testis size of 16.6 cm3 and right testis size of 12.4 cm3, a 0.65 cm 
cyst on the left epididymal head, left epididymal head enlargement, and widened bilateral 
pampiniform plexus. 
 
 Table 1. Testosterone Levels of  Serum LH and FSH Before and After Therapy 
 
 Before  After Normal Range 
Testosterone 1.06 ng/dl 6.74 ng/dl 2.8 – 8.0 ng/dl 
LH 0.546 mIU/ml < 0.1000 mIU/ml 0.5 – 9 mIU/ml 
FSH 1.8 mIU/ml 1.7 mIU/ml 1 - 8 mIU/ml 
 
 In April 2012, the patient underwent percutaneous epididymal sperm aspiration (PESA) 
and testicular sperm extraction (TESE). During the operation, no motile sperm from PESA 
aspirate or TESE tissue preparations were obtained (Table 2). Histopathological examination of 
biopsy tissue during TESE showed abnormal spermatogenesis process, which halted at the 
spermatid stage. A very minimal amount of spermatozoa were found in both testes. 
  
Table 2. Characteristics of Microscopic Findings in PESA and TESE, April 2012 
 
Before Washing After Washing 
PESA TESE PESA TESE 
Parameter 
Right Left Right Left Right Left Right Left 
Volume 1.5 ml 2 ml - - 0.2 ml 0.2 ml - - 
Motile sperm* 0 0 0 0 7x105 ml 3x105 ml 1/15 LP 1/10 LP 
Immotile 
sperm 
7.7x106 
/ml 
20x106 
/ml 
10/LP 10/LP 47x106 /ml 67x106 /ml 22/LP 20/LP 
Concentration 7.7x106 
/ml 
20x106 
/ml 
  47.7x106 
/ml 
67,3x106 
/ml 
  
Motility 0 % 0 % 0 % 0 % 1.47% 0.45 %   
*Motile sperm in place only 
 
 It was decided that microligation of bilateral varicocele and combined hormonal 
injection therapy (HCG and recombinant FSH) would be given. Bilateral spermativc vein 
microligation was conducted in June 2012 followed by  HCG and recombinant FSH injections 
given for 4 months. HCG was given 1000 IU for the first 2 months three times a week. The 
dosage was adjusted to 2500 IU for the next 2 months. Recombinant FSH was given 75 IU for the 
first 2 months three times a week, and the dosage was also adjusted to 150 IU for the next 2 
months. 
Table 1. Testosterone Levels of  Serum LH and FSH Before and After Therapy
In April 2012, the patient underwent 
percut eous epididymal sp rm aspiration (PESA) 
and testicular sperm extraction (TESE). During the 
operation, no motile sperm from PESA aspirate or 
TESE tissue preparations were obt ined (Table 
2). Histopathological examination of biopsy tissue 
during TESE showed abnor al spermatogenesis 
process, which halted at th  spermatid stage. A 
very mi imal amount of sperm tozo  were found 
in both t stes.
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Table 2. Characteristics of Microscopic Findings in PESA and TESE, April 2012
It was decided that microligation of bilateral 
varicocele and combined hormonal injection 
therapy (HCG and recombinant FSH) would be 
given. Bilateral spermativc vein microligation was 
conducted in June 2012 followed by  HCG and 
recombinant FSH injections given for 4 months. 
HCG was given 1000 IU for the first 2 months three 
times a week. The dosage was adjusted to 2500 IU 
for the next 2 months. Recombinant FSH was given 
75 IU for the first 2 months three times a week, and 
the dosage was also adjusted to 150 IU for the next 
2 months.
Post bilateral spermati vein microligation 
and hormonal injections, sperm analysis were 
performed again with more or less the same results 
as before therapy. It was decided to execute PESA 
and TESE. In the operations conducted in October 
2012, motile sperm in the left PESA were found. 
The couple underwent intra cytoplasmic sperm 
injection on November 2012 and currently the wife 
has already been conceived for 26 weeks. 
Discussion 
Infertility is a common problem. In the United 
States, approximately 15% of couples experience 
infertility, about 50-60% of it is attributable to 
the male factor.1 Azoospermia, the absence of 
spermatozoa in the semen as a result of testicular 
failure or obstruction of the reproductive tract, is the 
most severe form of infertility in men.9
Classification of azoospermia is generally 
divided into three: pre-testicular, testicular and 
post-testicular.1 In this patient, the possible risk 
factors for azoospermia were bilateral varicoceles 
(testicular factor) and low levels of testosterone 
and LH (pre-testicular factor).
Up to now there is a difference of opinions 
about the relationship between varicocele and 
fertility. Some stated that there is no association 
between varicocele and fertility. Uehling,10 found 
25% of varicocele in 440 married men. There 
were no differences in fertility in married men 
group (31%) and unmarried men group (32%). In 
a research on the characteristics of sperm in men 
with varicocele and without varicocele carried by 
Lund and Larsen,11 there were no differences in the 
number and motility of sperm, the percentage of 
normal sperm and the fecundity. 
Opposite opinion stated that a varicocele could 
cause testicular damage that plays a role in infertility. 
There is a clear relationship between varicocele 
and reduced male fertility, but few studies provide 
results that varicocele is associated with semen 
abnormalities, decreased testicular volume and 
decreased Leydig cell function.12,13
In this patient, varicocele surgery with bilateral 
spermatic vein microligation techniques was 
performed. Surgery on varicocele showed a positive 
effect, including improvement on the development 
of the testes, restoration of spermatogenesis 
function and increased fertility.13-15 In a literature 
review conducted by Cayan et al,16 microscopic 
varicocelectomy techniques yield higher 
spontaneous pregnancy rates, lower recurrence 
and lower possible complications of hydrocele than 
conventional techniques.
The cause of azoospermia in this patient 
was also considered to be pre-testicular factor. 
The patient suffered from hypogonadotropic 
hypogonadism. Preliminary examination showed 
low serum testosterone and luteinizing hormone 
levels (Table 1). Low serum testosterone levels 
alone can be primary or secondary. Testicular 
abnormalities in primary hypogonadism can be 
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caused by several etiologies, which comprise of 
genetic abnormalities (klinefelter syndrome as the 
most frequent), exposure to toxins or chemotherapy, 
congenital defects (anorchia or cryptorchidism), 
history of orchitis, history of trauma or torsion, 
drugs or increased testicular temperature (due to 
other reasons, such as varicocele).17,18
Secondary hypogonadism caused by disturbance 
in the hypothalamic-pituitary-gonadal axis can 
be congenital abnormalities such as kallman’s 
syndrome (anosmia and GnRH deficiency) and 
GnRH receptor deficiency and mutations, but can 
also be acquired, such as drugs, excess estrogen, 
diabetes mellitus, obesity and its related morbid 
conditions, hyperprolactinemia, old age, history of 
trauma and radiation, as well as other causes.17,19-23 
Low testosterone level in this patient were not 
thought as a result of the varicocele. Testicular 
abnormalities with low testosterone level will 
produce in a positive feedback on the pituitary and 
hypothalamus, thus will increase gonadotropin. 
Instead, in this patient a low luteinizing hormone 
level were obtained. Nevertheless, the risk factors 
for the hypogonadotropic hypogonadism state in 
this patient were not found.
Hypogonadotropic hypogonadism in this patient 
were treated by giving a combination hormone of the 
HCG and recombinant follicle stimulating hormone. 
HCG is a therapeutic option in low testosterone 
level because this hormone can stimulate the 
Leydig cells in secreting testosterone which will 
then increase spermatogenesis.24 In a clinical 
study, it was found that HCG can stimulate 
spermatogenesis in patients with azoospermia.
With HCG therapy without another hormone 
combination, the spermatogenesis process can 
be maintained even though the sperm count may 
be reduced over time.25 The state of falling sperm 
counts can be overcome by administering FSH.25 
Of a case report by Yong et al, a therapeutic effect 
on spermatogenesis and fertility were obtained 
from the combination of HCG and HMG (human 
menopausal gonadotropin) three times per week 
for 16 months. 26
The effectiveness of the combination of HCG 
and recombinant FSH had been demonstrated by 
a prospective study.27 Ten men with gonadotropin 
deficiency and low testosterone were given HCG 
therapy for 3-6 months and recombinant FSH 
for 18 months. Seven men showed presence 
of spermatogenesis process in 6 months and 
achieved the target number of sperm in 9 months 
FSH therapy. Three of the seven men can 
impregnate their partners. There was an increase 
in testicular volume. The study concluded that 
the combination of recombinant FSH and HCG is 
effective in the induction of spermatogenesis and 
fertility in patients with hipogonadotropin.27
In this patient, sperm aspiration was redone 
after HCG and recombinant FSH injection 
therapy. Positive results were found in the form 
of motile sperm in the left PESA. This showed the 
success of therapy in the form of the presence 
of spermatogenesis process in the patient after 
4 months of hormonal therapy. Further follow-up 
is still needed on this patient to assess whether 
the spermatogenesis continued and become 
progressively adequate, as demonstrated by the 
achievement of the target number of sperm and the 
occurrence of pregnancy in the patient’s partner.
Conclusion 
There is a positive response in the form of the 
occurence of spermatogenesis on azoospermic 
male after bilateral spermatic vein microligation 
follwed by combination hormonal therapy of HCG 
and recombinant FSH for 4 months. Further follow 
ups are still needed to evaluate the continuity and 
improvement of spermatogenesis process.
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